Skip to main content
. 2015 Oct 26;6(42):44466–44479. doi: 10.18632/oncotarget.6298

Figure 8. Clinical relevance of upregulation of miR-181c–mediated Hippo signaling inactivation in pancreatic cancer.

Figure 8

Expression analysis (left top) and correlation (right) of miR-181c expression and CTGF and BIRC5 mRNA levels, as well as (left bottom) nuclear YAP and TAZ protein expression in 10 freshly collected human pancreatic cancer tissue samples (T). The ratio of first sample (nuclear YAP/α-tubulin and nuclear TAZ/α-tubulin) was considered as 1.0. α-Tubulin was used as the loading control.